SCHEMBL7907883

SCHEMBL7907883

NCC(CN)CC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24653140 0.94 CACNA2D1 (0.65)
SCHEMBL27711954 0.86
SCHEMBL27799587 0.86
SCHEMBL28916626 0.84
SCHEMBL5322429 0.84
SCHEMBL23391156 0.84
SCHEMBL28993340 0.84
SCHEMBL28766834 0.84 CACNA2D1 (0.56)
SCHEMBL28916622 0.82 CACNA2D1 (0.54)
Hydrochloric Acid SCHEMBL28671037 0.82 CACNA2D1 (0.59)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107021952-B A kind of different luminol derivative and its preparation method and application 深圳市新产业生物医学工程股份有限公司 2019-09-17 CN claimed
CN-107021952-A A kind of different luminol derivative and its preparation method and application 深圳市新产业生物医学工程股份有限公司 2017-08-08 CN claimed
WO-2022218640-A1 RADIOPHARMACEUTICALS AT DIFFERENT ACTIVITY REFERENCE TIMES ITM Isotope Technologies Munich SE (DE) 2022-10-20 WO disclosed
CN-107021952-B A kind of different luminol derivative and its preparation method and application 深圳市新产业生物医学工程股份有限公司 2019-09-17 CN disclosed
CN-107021952-A A kind of different luminol derivative and its preparation method and application 深圳市新产业生物医学工程股份有限公司 2017-08-08 CN disclosed
EP-1853605-B1 INTEGRIN TARGETED SYNTHETIC LIGANDS FOR DIAGNOSTIC AND THERAPEUTIC APPLICATIONS BRACCO IMAGING SPA (IT) 2014-09-10 EP disclosed
US-8636977-B2 Integrin targeted synthetic ligands for diagnostic and therapeutic applications BRACCO IMAGING S.P.A. (IT) 2014-01-28 US disclosed
US-20110070249-A1 IMMUNIZING COMPOSITION AND METHOD FOR INDUCING AN IMMUNE RESPONSE AGAINST THE Beta-SECRETASE CLEAVAGE SITE OF AMYLOID PRECURSOR PROTEIN RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2011-03-24 US disclosed
US-7854931-B2 Immunizing compostion and method for inducing an immune response against the beta-secretase cleavage site of amyloid precursor protein RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2010-12-21 US disclosed
US-7541018-B2 Treatment process using somatostatin analogues UNIVERSITY OF BERN (CH) 2009-06-02 US disclosed
US-7541018-B2 Treatment process using somatostatin analogues UNIVERSITY OF BERN (CH) 2009-06-02 US disclosed
US-7494655-B2 antigenic peptides, antibodies and carriers, diluents, excipients, adjuvants or auxiliary agents, use for inhibiting the formation of beta-amyloid; treatment of Alzheimer's disease or Down's syndrome RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2009-02-24 US disclosed
US-20080317668-A1 Integrin Targeted Synthetic Ligands for Diagnostic and Therapeutic Applications BRACCO IMAGING S.P.A. (IT) 2008-12-25 US disclosed
US-20070172484-A1 IMMUNIZING COMPOSTION AND METHOD FOR INDUCING AN IMMUNE RESPONSE AGAINST THE BETA-SECRETASE CLEAVAGE SITE OF AMYLOID PRECURSOR PROTEIN RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2007-07-26 US disclosed
US-20070154392-A1 TREATMENT PROCESS USING SOMATOSTATIN ANALOGUES UNIVERSITY HOSPITAL BASEL (CH) 2007-07-05 US disclosed
US-20070154392-A1 TREATMENT PROCESS USING SOMATOSTATIN ANALOGUES UNIVERSITY HOSPITAL BASEL (CH) 2007-07-05 US disclosed
US-7192570-B2 Compositions of somatostatin analogues UNIVERSITY OF BERN (CH) 2007-03-20 US disclosed
US-7192570-B2 Compositions of somatostatin analogues UNIVERSITY OF BERN (CH) 2007-03-20 US disclosed
EP-0876161-B1 CONTRAST MEDIA NYCOMED SALUTAR INC (US) 2001-11-21 EP disclosed